Serogroup-Specific Bacterial Engineered Glycoproteins as Novel Antigenic Targets for Diagnosis of Shiga Toxin-Producing-Escherichia coli-Associated Hemolytic-Uremic Syndrome

Serodiagnosis Using Microagglutination Assay during the Food-Poisoning Outbreak in Japan Caused by Consumption of Raw Beef Contaminated with Enterohemorrhagic Escherichia coli O111 and O157

(2014) J. Isobe et al.   JOURNAL OF CLINICAL MICROBIOLOGY

A bacterial engineered glycoprotein as a novel antigen for diagnosis of bovine brucellosis

(2014) Andrés E. Ciocchini et al.   VETERINARY MICROBIOLOGY

Expanding the glycoengineering toolbox: the rise of bacterial N-linked protein glycosylation

(2013) Jenny L. Baker et al.   TRENDS IN BIOTECHNOLOGY

Development and Validation of a Novel Diagnostic Test for Human Brucellosis Using a Glyco-engineered Antigen Coupled to Magnetic Beads

(2013) Andrés E. Ciocchini et al.   PLoS Neglected Tropical Diseases

Exploiting the Campylobacter jejuni protein glycosylation system for glycoengineering vaccines and diagnostic tools directed against brucellosis

(2012) Jeremy A Iwashkiw et al.   Microbial Cell Factories

Antibody Response to Shiga Toxins in Argentinean Children with Enteropathic Hemolytic Uremic Syndrome at Acute and Long-Term Follow-Up Periods

(2011) Romina J. Fernández-Brando et al.   PLoS One

Escherichia coli O157

(2010) Hugh Pennington   LANCET

Protein glycosylation in bacteria: sweeter than ever

(2010) Harald Nothaft et al.   NATURE REVIEWS MICROBIOLOGY

Hemolytic uremic syndrome: pathogenesis and update of interventions

(2009) Marina S Palermo et al.   Expert Review of Anti-Infective Therapy

Human infections with verocytotoxin-producing Escherichia coli O157 - 10 years of E. coli O157 serodiagnosis

(2008) H. Chart et al.   JOURNAL OF MEDICAL MICROBIOLOGY